Adaps Competitors, Revenue, Alternatives and Pricing
Overview
Estimated Revenue & Financials
- Adaps's estimated annual revenue is currently $9M per year.
- Adaps's estimated revenue per employee is $145,000
Employee Data
- Adaps has 62 Employees.
- Adaps grew their employee count by 15% last year.
- Adaps currently has 1 job openings.
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Online Review | Pricing |
---|---|---|---|---|---|---|
Advertise Here | ||||||
#1 | $26.8M | 185 | N/A | N/A | - | N/A |
#2 | $13.3M | 92 | 23% | N/A | 4.6/5 | N/A |
#3 | $134.4M | 927 | 5% | N/A | - | N/A |
#4 | $1.2M | 8 | N/A | N/A | 4.5/5 | N/A |
#5 | $13.5M | 93 | 31% | N/A | 4.7/5 | N/A |
#6 | $4.6M | 32 | N/A | N/A | 5/5 | N/A |
#7 | $13.3M | 92 | 30% | N/A | - | N/A |
#8 | $6.5M | 45 | N/A | N/A | 5/5 | N/A |
#9 | $20M | 138 | N/A | N/A | - | N/A |
#10 | $0.9M | 6 | N/A | N/A | 4.5/5 | N/A |
What Is Adaps?
Established in 1964, Adaps is the oldest Australian owned IT company that functions with self-imposed high standards and well-defined processes. Adaps comes with a demonstrated track record combined with a perfect mixture of industry analysis and comprehensive research and can adhere to the clients requirements every single time to cater to industry specific demands. Adaps has a multi-faceted mission where the ultimate goal is to be the best in the industry. Here, we believe in value addition and time effective services that will best compliment our diverse range of clients. At the starting point, our mission is to deliver sustainable services in a strategic and cost-effective manner.
keywords:N/A62
Number of Employees
$9M
Revenue (est)
1
Current Jobs
15%
Employee Growth %
N/A
Total Funding
N/A
Valuation
N/A
Accelerator
N/A
Type
Adaps News
Last month, Lennon revealed he expects Shved to make a bigger impact once he adaps to his new surroundings. He said: "He's a little bit ...
Nesse sentido, ele elogiou a criação da Agência para o Desenvolvimento da Atenção Primária à Saúde (Adaps), que será responsável pela ...
The stock of Adaptimmune Therapeutics plc (NASDAQ:ADAP) has been Downgraded to Neutral from Buy by Guggenheim in its latest research ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding | Online Review | Pricing |
---|---|---|---|---|---|---|
#1 | $13.6M | 62 | 29% | N/A | - | N/A |
#2 | $17M | 63 | 7% | N/A | - | N/A |
#3 | $15.4M | 63 | 43% | N/A | - | N/A |
#4 | $15.9M | 63 | 26% | N/A | - | N/A |
#5 | $6.4M | 63 | 9% | N/A | - | N/A |